Growth hormone deficiency in adults
- Diagnostic test
Adults still need growth hormone for muscle, fat balance, bone and energy. Testing is only for people with a real reason to have pituitary damage.
See it in 3D: Pituitary gland · Hypothalamus
What it is
Adult growth hormone deficiency (GHD) is a lack of GH after growth is complete. It is either acquired, mostly from pituitary tumours and their treatment (surgery, radiotherapy), traumatic brain injury, apoplexy or infiltration, or childhood-onset and continued into adult life. It causes more visceral fat, less lean mass and exercise capacity, lower bone density, an adverse lipid profile and poorer quality of life, but none of these is specific. Because GH is pulsatile and falls with age and obesity, a single GH value cannot diagnose it, and a normal IGF-1 does not exclude it: diagnosis usually needs a stimulation test, applied only to patients with a high pre-test probability.
How to read the result
- Test only patients with hypothalamic-pituitary disease, previous surgery or radiotherapy, significant brain injury, or childhood-onset GHD.
- Three or more other pituitary deficiencies plus a low IGF-1 make GHD very likely: a stimulation test is usually unnecessary.
- A normal IGF-1 does not exclude GHD, especially in older adults.
- Obesity, ageing and poorly treated hypothyroidism blunt GH responses and cause false positives.
- Replace cortisol and thyroid hormone adequately before testing.
- Cut-offs depend on the test and, for the glucagon test, on BMI; they also depend on the GH assay.
How it is done
- Confirm a reason to test: pituitary disease, treatment, brain injury or childhood-onset GHD.
- Treat other deficiencies first and wait until the patient is stable.
- Measure IGF-1 against the range for age and sex.
- Low IGF-1 with three or more other deficiencies: GHD can be diagnosed without stimulation.
- Otherwise choose a stimulation test: insulin tolerance, glucagon, macimorelin or GHRH-arginine where available.
- Take timed GH samples after the stimulus and compare the peak with the test-specific cut-off.
- Childhood-onset GHD: retest at the end of growth after a pause in treatment, unless the cause is clearly permanent.
GH stimulation tests in adults
| Test | How it works | Strengths | Cautions |
|---|---|---|---|
| Insulin tolerance test | Hypoglycaemia stimulates GH and ACTH | Reference test; also tests the cortisol axis | Needs close supervision; avoid in seizures, heart disease and older age |
| Glucagon stimulation test | Glucagon triggers GH release by an indirect route | Widely available, safe | Long test; nausea; BMI-dependent cut-offs |
| Macimorelin test | Oral ghrelin-receptor agonist | Simple, oral, well tolerated | Limited availability; drug interactions |
| GHRH-arginine test | Direct pituitary stimulus | Reliable, not much affected by age | GHRH not available everywhere; misses hypothalamic causes such as after radiotherapy |
Common pitfalls
- GH treatment aims at symptoms and body composition; the dose is titrated to an IGF-1 in the normal range for age.
- Do not treat in active cancer or active proliferative diabetic retinopathy; use care in diabetes because GH raises insulin resistance.
- Side effects such as fluid retention, joint pain and carpal tunnel symptoms usually mean the dose is too high.
Next step / Initial management
- IGF-1 and the other pituitary axes first; stimulation testing only in patients with a clear reason.
- On treatment: IGF-1, glucose, free T4 and clinical review; cortisol if symptoms suggest it has been unmasked.
- Stop or reconsider treatment if quality of life does not improve after a fair trial.
- Refer to endocrinology for testing and treatment; GH is prescribed and monitored by specialists.
Common traps
- Tired adults should be tested for GH deficiency: without pituitary disease, a false-positive result leads to a wrong GHD diagnosis.
- A normal IGF-1 excludes GH deficiency: IGF-1 can be normal in true GH deficiency, so a stimulation test is needed when suspicion is high.
- GH testing can happen before other deficiencies are replaced: cortisol and thyroid deficiencies are replaced first.
- One glucagon-test cut-off fits every patient: obesity blunts the GH response, so cut-offs are adjusted for body mass index.
- Free T4 and cortisol need no recheck once GH starts: GH can unmask both deficiencies.
Test yourself
Think of the answer, then tap the question to see it.
Why is a stimulation test usually unnecessary in a patient with three other pituitary deficiencies and a low IGF-1?
GH is the first axis to fail; with three others lost and a low IGF-1, the pre-test probability of GHD is so high that a test adds little.
Why should GH not be tested in an obese, tired patient without pituitary disease?
Obesity blunts GH responses, so the test is likely to be falsely positive when the pre-test probability is low.
After GH is started, a patient with treated hypopituitarism becomes more tired and the free T4 has fallen. Why?
GH increases conversion of T4 to T3, unmasking central hypothyroidism; the levothyroxine needs adjusting.
Elsewhere in DurgiPedia
Connections
See it in 3D2
The structures of Durgical's 3D anatomy where it is found.
In Pharmacology3
Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.
Sources: Hypopituitarism (StatPearls (NCBI Bookshelf), 2023); Pituitary Adenoma (StatPearls (NCBI Bookshelf), 2025).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
